Fundraising Fox

VelosBio

San Diego, US · Founded 2017 · Delaware corporation · 4 known investors

velosbio.com ↗

A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.

Biotechin /merck@Merck

Founders & leadership

DJ
David JohnsonExecutive Officer, Director
CG
Cam GallagherDirector
SL
Scott L. GlennDirector

Investors · 4

Chiesi VenturesBoston · $5M
Sofinnova VenturesMenlo Park · $100K – $15M
Vedanta CapitalNew York
OrbiMedreportedNew York · $1M – $75M

Reported raises · per SEC filings

Form D private placements
▶$137MraisedJul 2020 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Min CuiDirector
  • Jayson PunwaniDirector
  • Karan TakharDirector
  • Alan ColowickDirector
  • Cam GallagherDirector
  • Clayton KnoxExecutive Officer
  • Jonathan TobinDirector
  • David JohnsonExecutive Officer, Director
  • Scott KarchmerExecutive Officer
  • Langdon MillerExecutive Officer
Offering amount
$137M
Amount sold
$137M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$59.3MraisedMay 2020 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott KarchmerExecutive Officer
  • Jonathan TobinDirector
  • Langdon MillerExecutive Officer
  • Alan ColowickDirector
  • David JohnsonExecutive Officer, Director
  • Jayson PunwaniDirector
  • Min CuiDirector
  • Clayton KnoxExecutive Officer
  • Cam GallagherDirector
Offering amount
$59.3M
Amount sold
$59.3M
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.5MraisedJul 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Min CuiDirector
  • David JohnsonExecutive Officer, Director
  • Jayson PunwaniDirector
  • Scott L. GlennDirector
  • Cam GallagherDirector
Offering amount
$6.5M
Amount sold
$6.5M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.7MraisedFeb 2018 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David JohnsonExecutive Officer, Director
  • Cam GallagherDirector
  • Scott L. GlennDirector
Offering amount
$7.7M
Amount sold
$7.7M
Proceeds to insiders
$350K
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news